NEW YORK (360Dx) – Quidel said on Tuesday that the US Food and Drug Administration has given 510(k) clearance and a CLIA waiver for its Sofia Influenza A+B fluorescent immunoassay operating on the Sofia 2 analyzer.

The combination is cleared for use in the rapid, differential detection of Influenza types A and B from direct nasal swab, nasopharyngeal swab, and nasopharyngeal aspirate/wash specimens, and nasopharyngeal swab and nasopharyngeal aspirate/wash specimens in transport media from symptomatic patients, Quidel said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.